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Background: Atherosclerosis is a major health burden. Metabolic disorders had been associated with large
consumption of soft drinks. The rising incidence of atherosclerosis and metabolic alterations warrants the study of
long-term soft drink consumption’ effects on metabolism and atherosclerosis in genetic deficiency of
apolipoprotein E which typically develops spontaneous atherosclerosis and metabolic alterations.
Methods: ApoE-/- mice were randomized in 3 groups accordingly with free access to: water (W), regular cola (C) or
light cola (L). After 8 weeks, 50% of the animals in each group were euthanized (Treatment: W8, C8, L8). The
remaining mice (all groups) drank water for 8 weeks and were euthanized (Washout: W16, C16, L16). Body weight
and food and drink consumption were periodically measured. Blood was collected (biochemistry). At autopsy,
transverse aortic sinus sections were serially cut and stained (histomorphometry); livers and kidneys were processed
(microscopy). MANOVA (identification of variance factors) was followed by ANOVA and LSD tests (within-factor
differences between levels). Conventionally a p< 0.05 was considered significant.
Results: Treatment increased drinking volumes (vs W8: 4 fold C8, p<0.0001; +47% L8, p<0.02). Only C reduced
eating amounts (–54%, p<0.05 vs W8). I). Compared with W8: C8 developed hyperglycemia (+43%, p<0.03) and
increased non-HDL cholesterol (+54%, p<0.05); L8 showed decreased glycemia (–15%, p<0.05 vs W8) and increased
creatinine (2.5 fold, p<0.04), urea (+74, p<0.03) and aspartate-aminotransferase (2.8 fold, p<0.05). Hypercreatininemia
was observed in L16 (2.7 fold vs W16, p<0.05). Hypertriglyceridemia (+91%, p<0.008) and hyperuremia (+68%,
p<0.03) developed over time of study (age). II). Treatment caused plaque area increase (vs W8: 28% C8, p<0.02 and
50% L8, p<0.01; vs W16: 43% C16, p<0.05 and 68% L16, p<0.02) and stenosis (vs W8: 38% C8, p<0.04 and 57% L8,
p<0.01; vs W16: 71% C16, p<0.01 and 46% L16, p<0.04). Age also caused plaque area increase (56%, p<0.04).
Treatment- and age-effects on plaque enlargement were additive.
Conclusion: Cola beverages caused atherosclerotic lesions’ enlargement with metabolic (C) or non metabolic
disturbances (L). ApoE-/- mice were particularly sensitive to L treatment. These findings may likely relate to caramel
colorant and non-nutritive sweeteners in cola drinks and have potential implications in particularly sensitive individuals.
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Atherosclerosis is a major health burden in modern so-
ciety and a leading cause of death worldwide [1]. The
rising consumption of soft drinks has been linked to the
growing incidence of metabolic syndrome [2,3]. Previ-
ously we reported metabolic and cardiovascular alter-
ations associated with cola drinking in normal (eugenic)
rats [4,5]. The main components of metabolic syndrome
(obesity, diabetes, hypertension) are known risk factors
for atherosclerosis. However we have not found infor-
mation concerning with the possible consequences of
long-term cola drinking on atherosclerosis. The inci-
dence of atherosclerosis and metabolic alterations is ris-
ing and warranted the study of the effects of long-term
soft drink consumption on metabolism and atheroscler-
osis in genetic deficiency of apolipoprotein E. Apolipo-
protein E deficient (ApoE-/-) mice are a murine model
of spontaneous atherosclerosis and develops metabolic
abnormalities [6].
This is a descriptive study reporting the effects of
long-term consumption of regular cola (sucrose sweet-
ened) and light cola (aspartame-acesulfame K sweet-
ened) on a). blood chemistry composition and b).
atherosclerotic lesions in the aortic sinus (morphology,
morphometry and instability features). The ApoE-/-
mouse was used as a model of atherosclerosis and meta-
bolic disorder because of the potential implications of
the resulting information on some individuals with
personal or familiar history of atherosclerosis or meta-
bolic disorders.Materials and methods
Animals
Forty-eight Apo E knockout (ApoE-/-) mice (25 female,
23 male) on a C57BL/6 background were obtained from
the Jackson Laboratory (Bar Harbor, Maine). All
animals were fed on a standard rodent commercial
chow (16%–18% protein, 0.2 g% sodium, Cooperación,
Buenos Aires, Argentina) ad libitum and housed inside
an indoor laboratory facility with a 12 h light/dark cycle.
The experiments were approved by The Animal Care
Committee of the University of Buenos Aires and were
performed in compliance with the ARRIVE guidelines
on animal research [7].Experimental design
ApoE-/- mice (8 week-old) were randomly distributed in 3
groups accordingly with free access to one of the following
drinks: water (W), regular cola (C) (sucrose sweetened
carbonated drink, Coca-Cola™, Argentina), or light cola
(L) (low calorie aspartame–acesulfame K sweetened car-
bonated drink, Coca-Cola Light™, Argentina). Cola drinkshad carbon dioxide content largely removed by vigorous
shaking using a stirring plate and placing a magnetic bar
in a container filled with the liquid prior to being offered
to the animals at room temperature. After 8 weeks, 50%
of the animals in each group were euthanized (Treatment:
W8, C8, L8). The remaining mice (all groups) drank water
for another 8 weeks (i.e.: 16 weeks from beginning of the
study) and were then euthanized (Washout: W16, C16, L16).
The ratio male/female was 1/1 in all groups except for L16
(3/5). The animals were weighed weekly. Food and drink
consumption were measured twice a week. Heparinized
blood was collected and plasma was separated for biochem-
ical assays. At autopsy, transverse aortic sinus sections were
serially cut and stained for histomorphometry and livers
and kidneys were processed for microscopic assessment.
According to company specifications, Coca Cola™ is a
carbonated water solution containing (in 100 mL):
carbohydrate 10.6 g, sodium 7 mg, caffeine 11.5 mg,
caramel, phosphoric acid, citric acid, vanilla extract,
natural flavourings (orange, lemon, nutmeg, cinnamon,
coriander, etc.), lime juice and fluid extract of coca
(Erythroxylon novogranatense). As far as nutritional in-
formation is concerned, the only difference between
regular (43 Kcal/100 mL) and light cola (0 kcal) is the
replacement of carbohydrates with non-nutritive sweet-
eners (aspartame 24 mg/100 mL–acesulfame K 16 mg/
100 mL).Sample handling
Animals were sacrificed under anesthesia with sodium
pentobarbital and sodium diphenylhydantoin (EuthanylW).
Blood samples were obtained by ventricular puncture and
plasma was separated. Commercially available kits were
used for plasma analysis and measurement of: glucose
using an enzymatic-colorimetric kit (Sigma Chemical Co.,
St. Louis, MO, kit #315–100) followed by spectrophometry;
cholesterol using enzymatic kits (Sigma Chemical Co., St.
Louis, MO, kit #402–20) and triglycerides (Sigma Chemical
Co., St. Louis, MO, kit #344–20). Lipoproteins were sepa-
rated by sequential density ultracentrifugation (density
ranges: HDL 1.063–1.210 g/mL, HDL < 1.063 g/mL using a
TLA-100 rotor (Beckman Instruments, Palo Alto, CA).
Liver fragments, sagital sections from both kidneys, the
heart and the ascending aorta were dissected and immersed
in 10% buffered formaldehyde (Formalin 10% buffered solu-
tion, pH= 7.0) at room temperature for at least a 24 h fix-
ation. After dehydration (graded ethanol series of 50%, 70%,
and 100%), tissues were embedded in paraffin blocks.
Six serial transverse sections (5 μm) were cut through the
aorta at the origins of the aortic valve leaflets throughout
the entire aortic sinus and stained with hematoxylin-eosin,
Heidenhain trichrome (Azan) and orcein for elastic
fiber identification.
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Features of plaque instability [8] were evaluated according
with the presence of 3 or more of the following criteria:
thickness of the fibrous cap (thin fibrous cap was defined
as 3 or fewer cell layers), size of the necrotic core (a large
necrotic core was defined as occupying more than 1/3 of
the volume of the plaque), intraplaque hemorrhage
(defined as the presence of red blood cells independent of
microvessels) and the deposition of cholesterol crystals.
Results were computed as binary outcomes and the
frequency for each group was determined. Each of six ser-
ial cross sections was analysed using a software-coupled
(Image Pro Plus for Windows, v3) Nikon Eclipse E400
microscope and data were averaged. In addition, plaque
area, intimal layer and the media layer length were mea-
sured and stenosis percentage was calculated.
Statistical analysis
Data were overall analyzed by multiple analysis of variance
test (MANOVA) to identify sources of variation. Main ef-
fects and interactions were opened, followed by one way
ANOVA and post hoc tests (LSD, least significant differ-
ence) to detect differences between levels (experimental
groups) within each source of variation (within factor).
Conventionally a p< 0.05 was considered significant (SPSS™
version 17.0 software).Results
Blood chemistry
Cola beverages treatment increased drinking volumes
(C8: 4 fold, p<0.0001 and L8: +47%, p<0.02 vs W8). Only
regular cola reduced food consumption (–54% C8, p<0.05
vs W8) (Table 1). Compared with W8: C8 developed
hyperglycemia (+43%, p<0.03) and higher non-HDL choles-
terol levels (+54%, p<0.05) so that hyperglycemia accounted
for 83% of non-HDL cholesterol increase (p< 0.001); L8
had lower glycemia (–15%, <0.05) and increased levels of
creatinine (2.5 fold, p<0.04), urea (+74, p<0.03) and-
aspartate aminotransferase (AST) (2.8 fold, p<0.05).
These changes reversed after treatment discontinuation
except for persistent hypercreatininemia as found in L16
(2.7 fold vs W16, p<0.05). Over time of study (mice ageTable 1 Body weight and nutritional data of ApoE-/- mice aft
Group W8 C8
BW (g) 21.4 ± 2.2 23.7 ± 3.0
Solid intake (g) 3.7 ± 0.3 1.7 ± 0.2
Liquid intake (mL) 4.9 ± 1.1 21.1 ± 1.6
Solid intake/BW (g/g) 0.17±0.02 0.07±0.01
Liquid intake/BW (mL/g) 0.23±0.02 0.89±0.06effect) hypertriglyceridemia (+91%, F1,46=7.69, p<0.008)
and hyperuremia (+68%, F1,46=5.01, p<0.03) developed
(Figure 1).
Morphological and morphometric study of atheroma
lesions
All 3 groups of mice developed qualitatively similar athero-
sclerotic lesions, but showed quantitative differences
according with the group. The overall picture was repre-
sented by larger lesions in cola beverages treated mice (see
differences below). As shown in Figure 2, the aortic plaques
extended from the endothelium to the internal elastic
membrane, bulging into the arterial lumen. Along with
this, luminal caliber was reduced with thickening or thin-
ning and even disruption of the fibrous cap. Extensive atro-
phy of the aortic media was observed, being replaced with
plaque components, consisting of huge acellular necrotic
xanthomas shaped into fibro-fatty nodules of cholesterol
crystals surrounded by dense or loose connective tissue. In-
ternal and external elastic membranes were disrupted and
discontinued or even disappeared at the site of plaque ex-
pansion. In some sections, the ostia to the coronary arter-
ies were mildly or largely obstructed by the plaque. Aortic
leaflets were thickened and their free borders often
presented linear calcifications and/or loose fibrotic excres-
cences (Figure 2).
Treatment caused irreversible increase in plaque area
(Figure 3) (vs W8: 28%, p<0.02 in C8 and 50%, p<0.01 in
L8; vs W16: 43%, p<0.05 in C16 and 68%, p<0.02 in L16) and
stenosis (vs W8: 38%, p<0.04 in C8 and 57%, p<0.01 in L8;
vs W16: 71%, p<0.01 in C16 and 46%, p<0.04 in L16). Age
was overall associated with plaque area increase (56%,
F2,42=3.48, p<0.04). Treatment and age had additive effects
on plaque area and did not interact with each other
(FTreatment*Age 2,42=2.17, N.S.).
Plaque instability features showed no variation related
to group (inset table in Figure 3).
Liver and kidney morphology
Treatment with cola beverages had no effect on the
morphology or the aging process of these organs. Ac-
cordingly all mice regardless of the group showed a mild
degree of liver steatosis and scattered foci of acinar in-
flammation, whereas only a slight chronic interstitialer cola beverages treatment and after washout
L8 W16 C16 L16
20.6 ± 1.9 23.2 ± 2.0 24.5 ± 3.1 22.9 ± 2.8
3.8 ± 0.3 3.8 ± 0.4 3.3 ± 0.3 4.1 ± 0.4
7.2 ± 0.7 4.7 ± 0.4 4.5 ± 0.4 5.9 ± 0.9
0.18±0.02 0.16 ± 0.02 0.18±0.02 0.18±0.02
0.35±0.03 0.20 ± 0.03 0.18±0.02 0.26±0.03
Figure 1 Blood chemistry in ApoE-/- mice after cola beverages treatment and after washout. Data are expressed in mg/100 mL except for
enzymes (AST and ASL) activity which is expressed in units/L. An enzyme unit is defined as the amount of enzyme catalyzing the transamination
of 1 μmol substrate, aspartate or alanine respectively, in 1 min at 20–25°C/68–77°F.
Figure 2 Aortic plaque histology from an ApoE-/- mouse after cola beverage treatment. The image corresponds to one of six serial sections
obtained where the aortic sinus becomes the ascending aorta. The aortic plaque extends from the lumen to the internal elastic membrane. Along with
this, luminal caliber is reduced with thickening or thinning and even disruption (solid arrow) of the fibrous cap. Extensive atrophy of the aortic media is
observed, being replaced with plaque components, consisting of huge acellular necrotic xanthomas shaped into fibro-fatty nodules of cholesterol
crystals and dense or loose connective tissue. Internal and external elastic membranes are disrupted and discontinued at the site of plaque expansion.
The arrow identifies the ostia to a coronary artery which is largely obstructed by the plaque (empty arrow). Aortic leaflets are thickened and their free
borders show linear calcifications and loose fibrotic excrescences (1–3). Hematoxylin and eosin x 200.
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Figure 3 Atherosclerosis after cola beverages treatment and after washout. Figure depicts plaque area and stenosis percentage results.
Inset table shows data for plaque instability features.
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tween the outer and internal medullar zones were ob-
served in the kidneys (not shown).
Discussion
In this paper, whereas predictable results were observed
after the administration of regular cola to ApoE-/- mice,
light cola consumption revealed unexpected observations.
Neither regular cola nor light cola drinking modified body
weight. Interestingly, solid food intake decreased in the
regular cola group, likely as the result of drinking large vol-
umes of regular cola which provided excess caloric intake.
We reported the same nutritional behavior in eugenic rats
after drinking regular cola for a long period [4,5].Blood chemistry
Regular cola drinking (C, sucrose sweetened) resulted in
hyperglycemia which largely accounted for the observedincrease in the non-HDL cholesterol fraction. These
changes reversed after the washout period. Differently,
light cola drinking (L, aspartame–acesulfame K sweet-
ened) induced a mild decrease in glycemia, with
hypercreatininemia, hyperuremia and increase in AST,
all of which reversed after washout except for
hypercreatininemia. Acesulfame K and other non-nutritive
sweeteners (but not aspartame) have been reported to ac-
tivate enteroendocrine sweet taste receptors and release
incretins which stimulate pancreatic insulin secretion
[9-11]. Reasonably, this mechanism might help to
understand the decrease in glycemia observed in the L
group. Likewise, phenylalanine, 40% of metabolilzed as-
partame [12], acting synergically with solid food and
stimulating insulin release [13] might participate in the
decrease in glycemia in L group.
Reduced creatinine clearance has been reported in
8 week-old (young) ApoE-/- mice [14] indicating some
degree of vulnerability in glomerular filtration. Oxidative
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methanol ocurrence in blood [15]. In L mice uremic tox-
icity and increased oxidative stress may correlate with a
pro-inflammatory condition. However liver pathology
was not detectable by optic microscopy in this study. A
temporal delay between biochemical changes and mor-
phological alterations may partly contribute to explain
the lack of correlation.
Over time of study hypertriglyceridemia and hyperuremia
developed in all groups irrespective of drink treatment
likely as a result of the aging process which is typically
accelerated in ApoE-/- mice.Arterial pathology
Cola drinking resulted in enlargement of atherosclerotic
lesions and increased stenosis. Time over study (aging)
was per se associated with both increased plaque area and
stenosis. After washout further worsening of atheroscler-
otic lesions (i.e. enlargement of plaque area and increase
in stenosis degree) observed in mice that had consumed
colas was interpreted as a result of aging.
Recently, safrole-20,30-oxide (main component of sassafras
oil in nutmeg) which is found in cola beverages, has been
reported to aggravate atherosclerosis in ApoE−/− mice [16].
It is known that lipid profile and atherosclerosis are
influenced by gender in mice, particularly in ApoE−/−
mice [17-19]. However, the influence of gender on ath-
erosclerosis and the protective effect of estrogens are
not yet clear [20-22]. We observed only a trend towards
increased total cholesterol levels in males compared to
females. One likely explanation is that the number of an-
imals per gender was too small.Possible mechanisms responsible for the effects of cola
drinking on aortic sinus plaque
Atherosclerosis in ApoE-/- mice can be affected by several
factors. Defective insulin secretion, smaller islet mass and
islet inflammation have been found in atherosclerosis-
susceptible B6.ApoE-/- mice compared to atherosclerosis-
resistant BALB.ApoE-/- mice (C57BL/6 and BALB/cJ
respectively) [23]. Present finding of hyperglycemia after
chronic regular cola drinking may be consistent with
such possibility, i.e: reduced beta cell mass and insulin se-
cretion which have not been evaluated in this study. We
have observed islet mass reduction with hyperglycemia
after chronic regular cola drinking in rats (unpublished
observations). Genetic deficit or pharmacological blockade
of angiotensin receptor 1 (AT1R) attenuates atheroscler-
osis and improves endothelial function in experimentally
induced diabetes in ApoE−/− mice via peroxisome proli-
ferator-activated receptor γ (PPARγ) pathway [24,25]. We
have found no reports relating cola drinking with ATR1 or
the PPARγ pathway.Caramel colorant, contained in both regular and light
cola beverages. is a source of advanced glycation end
products (AGEs) [3,4] promoting a proatherogenic pro-
oxidative status [26].
Uremia and even mild renal dysfunction have been
reported to cause a dramatic increase in plaque size and
aggressive morphology (foam cell rich soft plaques) in
ApoE-/- mice [27]. High uremia, which has been associ-
ated with a prooxidative and proinflamatory condition,
was presently observed after chronic light cola drinking
[15]. In addition, the generation of ROS by methanol origi-
nated by aspartame cleavage offers a reasonable mechan-
ism underlying the effects of light cola drinking. Also
unmetabolized aspartame, 10–15% of ingested aspartame
[28], modifies the intestinal environment and triggers in-
flammatory (pro-atherogenic) processes [11].
In this study light cola drinking caused hyperuremia and
atherosclerosis in 16 weeks-old mice (8 weeks-old mice at
the beginning of the study + 8 week-treatment) while these
conditions typically develop in aged ApoE-/- mice [29-31].
Accordingly, it follows that long term L consumption might
precipitate aging mechanisms in arterial vessels in suscep-
tible hosts.
Conclusions
ApoE-/- mice were particularly sensitive to the effects of
light cola drinking. Increase in AST, uremia and
creatininemia suggest functional interference at one or
more levels (liver, kidney, muscle) and warrants future
research.
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